Core Insights - Cibus, Inc. announced that two of its disease resistance trait products for canola have been designated as not regulated by USDA-APHIS, allowing unrestricted product development in the U.S. [1][2] Regulatory Developments - The two trait products were developed using Cibus' Rapid Trait Development System™ (RTDS®), enabling targeted genetic changes without recombinant DNA integration, thus not meeting the definition of a "regulated article" [2] - This designation aligns with evolving regulatory frameworks globally, including the EU's recent endorsement of regulations for plants developed by New Genomic Techniques (NGTs) [3] Product Benefits - Cibus' Sclerotinia resistance trait in canola provides multiple modes of action, improving yields and reducing reliance on fungicides, which are essential for controlling Sclerotinia sclerotiorum, a significant pathogen affecting canola and other crops [4] - The disease can reduce canola yields by 7-15%, with losses per infected plant reaching up to 50% [4] Strategic Focus - Cibus aims to extend the application of its traits to other crops like soybean, addressing climate change impacts on plant diseases [5] - The company focuses on developing and licensing gene-edited productivity traits to seed companies, targeting major global row crops such as canola, rice, and soybean [5]